IVESU Trademark

Trademark Overview


On Friday, February 16, 2018, a trademark application was filed for IVESU with the United States Patent and Trademark Office. The USPTO has given the IVESU trademark a serial number of 87800958. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 31, 2022. This trademark is owned by Eli Lilly and Company. The IVESU trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use i...
ivesu

General Information


Serial Number87800958
Word MarkIVESU
Filing DateFriday, February 16, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 31, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 30, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 24, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, January 31, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 31, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 19, 2021SOU EXTENSION 5 GRANTED
Monday, May 17, 2021SOU EXTENSION 5 FILED
Monday, May 17, 2021SOU TEAS EXTENSION RECEIVED
Thursday, November 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 18, 2020SOU EXTENSION 4 GRANTED
Tuesday, November 17, 2020SOU EXTENSION 4 FILED
Tuesday, November 17, 2020SOU TEAS EXTENSION RECEIVED
Friday, May 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 20, 2020SOU EXTENSION 3 GRANTED
Wednesday, May 20, 2020SOU EXTENSION 3 FILED
Wednesday, May 20, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2019SOU EXTENSION 2 GRANTED
Friday, November 22, 2019SOU EXTENSION 2 FILED
Friday, November 22, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, June 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 10, 2019SOU EXTENSION 1 GRANTED
Wednesday, June 5, 2019SOU EXTENSION 1 FILED
Monday, June 10, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 5, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, December 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 30, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 30, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 10, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 21, 2018ASSIGNED TO LIE
Thursday, September 6, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 5, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 5, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 5, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 26, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 26, 2018NON-FINAL ACTION E-MAILED
Monday, March 26, 2018NON-FINAL ACTION WRITTEN
Monday, March 26, 2018ASSIGNED TO EXAMINER
Saturday, February 24, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 20, 2018NEW APPLICATION ENTERED